AbbVie Inc. (ABBV)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 10:25AM EDT. Market open.
| Previous Close | 170.75 |
| Open | 170.29 |
| Bid | 170.93 x 1200 |
| Ask | 171.10 x 1000 |
| Day's Range | 170.24 - 171.81 |
| 52 Week Range | 130.96 - 182.89 |
| Volume | |
| Avg. Volume | 5,331,464 |
| Market Cap | 300.94B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 50.72 |
| EPS (TTM) | 3.36 |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 6.20 (3.63%) |
| Ex-Dividend Date | Jul 15, 2024 |
| 1y Target Est | 184.08 |
ZacksAbbVie (ABBV) Stock Dips While Market Gains: Key Facts
AbbVie (ABBV) reachead $170.75 at the closing of the latest trading day, reflecting a -1.15% change compared to its last close.
PR NewswireAbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson's disease.
ZacksHere's Why You Should Consider Buying Alvotech (ALVO) Stock
Here, we discuss some reasons why buying Alvotech (ALVO) stock now may turn out to be a prudent move.
© 2024 Yahoo. All rights reserved.